Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ·Healthcare·Biotechnology
$10.04
-5.48%
Mkt Cap $217.75M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$27.00
Range $27.00 – $27.00
Implied Upside
+168.9%
Consensus $27.00 vs current $10.04